Major players in the fitness tracker market are Apple Inc. , Garmin Ltd. , Google LLC (Alphabet Inc. ), Huawei Technologies Co Ltd. (Huawei), NIKE Inc. , Samsung Electronics Co Ltd, Xiaomi Inc, Adidas Inc, Jawbone, Polar, Beienda, Ambiotex GmbH, Hexoskin, Fossil Group Inc.
New York, Sept. 08, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Fitness Tracker Global Market Report 2022” – https://www.reportlinker.com/p06318597/?utm_source=GNW
, and TomTom N.V.
The global fitness tracker market is expected to grow from $31.80 billion in 2021 to $38.34 billion in 2022 at a compound annual growth rate (CAGR) of 20.5%. The fitness tracker market is expected to grow to $78.35 billion in 2026 at a CAGR of 19.6%.
The fitness tracker market consists of sales of fitness trackers by entities (organizations, sole traders, and partnerships) that are used for health and fitness tracking.A fitness tracker refers to a device that uses sensors to track orientation, movement, and rotation.
The device collects data and converts it into steps, calories, sleep quality, and overall activity performed by the wearer during the day.A fitness tracker can easily figure out whether a wearer is running or spinning.
The main device types in the fitness tracker market are smart watches, fitness banks, smart glasses, smart clothing and other device types.A smartwatch refers to a digital watch that provides many other features besides timekeeping.
The various applications involved are heart rate tracking, sleep measurement, glucose measurement, sports, running and cycling tracking. The distribution channels are online, retail, and other distribution channels.
North America was the largest region in the fitness tracker market in 2021.Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the fitness tracker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The fitness tracker market research report is one of a series of new reports that provides fitness tracker market statistics, including fitness tracker industry global market size, regional shares, competitors with a fitness tracker market share, detailed fitness tracker market segments, market trends and opportunities, and any further data you may need to thrive in the fitness tracker industry. This fitness tracker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The increasing incidence of health disorders is expected to propel the growth of the fitness tracker market going forward.A health disorder refers to a condition that has known physical causes and visible psychopathology.
With a fitness tracker, there will be physical activity every day, which helps in preventing various health disorders.For instance, in 2020, according to the World Health Organization, a US-based government agency, chronic disease prevalence is expected to rise by 57%.
Therefore, the increasing incidence of health disorders is driving the growth of the fitness tracker market.
Technological advancement is a key trend gaining popularity in the fitness tracker market.Major companies operating in the fitness tracker market are engaging in technological advancements to sustain their position in the market.
For instance, in April 2021, Fitbit, a US-based consumer electronics and fitness company that is operating in the fitness tracker market, launched Fitbit Luxe, a fashion-forward health and wellness tracker with the fundamentals like heart and sleep tracking, breathing rate, stress management, and other such features.It added a touch of luxury with a stainless steel case and colour AMOLED display technology.
It has a blood oxygen sensor and keeps track of stress with a daily stress score, sleep, heart rate, steps, active zone minutes, and 50-meter water resistance.
In January 2021, Google, a US-based technology company, acquired Fitbit for an amount of $2.1 billion. Through this acquisition, Google aims to expand its fitness platform portfolio and make health and wellness more accessible to more people. Fitbit is a US-based consumer electronics and fitness company that produces wireless-enabled wearable technology, physical fitness monitors, and activity trackers such as smartwatches.
The countries covered in the fitness tracker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Read the full report: https://www.reportlinker.com/p06318597/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
Nio (NYSE: NIO) stock exploded this morning and was trading nearly 10.3% higher as of 11 a.m. ET Monday. An analyst who closely tracks the Chinese electric vehicle (EV) market just singled out the hot stock as his top EV pick in China and sees Nio shares doubling in value over the next 12 months, backed by two big growth catalysts. Deutsche Bank analyst Edison Yu has two reasons why Nio could outperform and emerge as the leader among EV start-ups, according to The Fly.
Shares of Gilead Sciences Inc. were up 5.2% in premarket trading on Monday after the company said in a securities filing that it settled a patent case that extends the exclusivity of its HIV franchise. The drug cited in the case is tenofovir alafenamide, which is included in the formulation of several Gilead therapies, including Biktarvy and Truvada. Gilead said it agreed to a non-exclusive license with several generic drug manufacturers – Cipla Ltd. , Lupin Ltd. , Apotex Inc., Macleods Pharmace
A Tilray press release last week seems to have caused some dismay among Germany's drug regulators.
Spectrum Pharmaceuticals (SPPI) receives FDA approval for its drug candidate, Rolvedon (eflapergrastim), for treating chemotherapy-induced neutropenia.
Warren Buffett's company Berkshire Hathaway has invested in some stocks this year trading at rock-bottom valuations.
Shares of Apple (NASDAQ: AAPL) climbed higher on Monday, adding as much as 3.5%. Wedbush's Daniel Ives has been keeping a close eye on Apple's website and notes that delivery times have quickly been pushed out to mid-October for the more expensive iPhone 14 Pro models, while the remaining preorders will take at least three weeks to process and wait times are quickly getting longer, according to The Fly. Ives noted that not only are iPhone 14 orders tracking ahead of his expectations, but consumers are ordering more Pro and Pro Max models, which will drive up the average selling price (ASP) for Apple.
Good news from the Food and Drug Administration (FDA) can send biotech stocks into the stratosphere. Patrick Bafuma (Mirati Therapeutics): One company that has to be champing at the bit to get FDA approval is Mirati Therapeutics, with its lead drug adagrasib.
Yahoo Finance Live anchors discuss reports that President Biden is ramping up China export restrictions.
Amazon is diving deeper into robotics. As the company announced on its AboutAmazon.com blog on Friday, Amazon has just signed a deal to acquire Belgian "mechatronics solutions" company Cloostermans. Amazon noted on its blog that it has been using Cloostermans technology "to help move and stack heavy pallets and totes or package products together for customer delivery" since 2019 already.
Every investor in XPeng Inc. ( NYSE:XPEV ) should be aware of the most powerful shareholder groups. The group holding…
In this article, we discuss 10 dividend stocks to buy according to billionaire Carl Icahn’s Icahn Capital LP. You can skip our detailed analysis of Icahn’s investment strategy and his performance in the past, and go directly to read 5 Dividend Stocks to Buy According to Billionaire Carl Icahn’s Icahn Capital LP. Carl Icahn started […]
While Honda (HMC) revs up its e-mobility game by collaborating with Hanwa for the procurement of EV batteries, NIO incurs a loss of 25 cents per ADS in Q2, despite improved deliveries.
In this article, we discuss the 10 best energy stocks to buy now. If you want to skip our industry overview, take a look at the 5 Best Energy Stocks to Buy Now. The Covid-19 pandemic was difficult for the energy sector. Global travel restrictions brought on by the Covid-19 outbreak reduced demand for oil […]
Late Friday, Bristol Myers Squibb (ticker: BMY) announced that the Food and Drug Administration had approved its oral plaque psoriasis treatment deucravacitinib, which will be marketed under the name Sotyktu. More surprising than the approval was the FDA’s decision not to require a so-called “black-boxed warning” on the drug’s label, which the agency uses when a drug carries significant safety risks. Investors had been concerned that similarities between TYK2 inhibitors and another class of drugs, known as Janus kinase inhibitors, which have been the subject of significant FDA safety concerns, would lead the agency to put a black box on Sotyktu.
Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.
Miller Tabak + Co.'s chief market strategist Matt Maley has his eye on three troubled areas of financial markets right now. He thinks investors need to be looking at them too.
The tech-heavy Nasdaq Composite is currently 24% off its high, putting the index in bear market territory, and many individual stocks have fallen even further. For instance, Roku (NASDAQ: ROKU) and Shopify (NYSE: SHOP) are down 68% and 74%, respectively. Roku is the most popular streaming platform in the U.S., Canada, and Mexico as measured by viewing hours.
Zacks.com users have recently been watching Enterprise Products (EPD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In this article, we will take a look at the 10 best penny stocks to buy in September. If you want to skip our discussion on the current US economic situation, go directly to the 5 Best Penny Stocks to Buy in September. The US equity markets have been experiencing a sell-off in the past three […]
Walt Disney (NYSE: DIS), Wayfair (NYSE: W), and Home Depot (NYSE: HD) are great stocks you can still buy on sale now. It's still launching in new markets and expecting 230 million to 260 million Disney+ subscribers by 2024, by which time it expects Disney+ to break even.